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)e *eld of neuroimmunology is providing growing evidence
of active crosstalk between the immune system and the
nervous system in health and during diverse pathological
conditions. Experimental and clinical research now sug-
gests that signaling from periphery to brain is important
for maintaining homeostasis, but also has the potential to
impact brain disease initiation or progression. Knowledge
and understanding of the cellular andmolecularmechanisms
governing immune-to-brain bidirectional communication is
providing key insights to better model neuroimmune com-
munication, understand the clinical implications, and design
better therapies for CNS disorders with an in!ammatory
component.
)is special issue contains 16papers, representing original
research articles, clinical research articles, and reviews, rang-
ing from detailed studies of the key molecular determinants
of the neuroin!ammatory reaction to the complex neuroim-
mune component of diverse neurological diseases.
“Systemic immune activation leads to neuroin)ammation
and sickness behavior inmice” by S. Biesmans et al. describes a
study that investigates the e,ect of systemic LPS administra-
tion on the CNS by assessing changes of glial cells, cytokine
production, and various behavioural tasks.)e use of GFAP-
luc mice provides novel insight into the glial response to
systemic in!ammation.)e study also provides insights into
the kinetics of behavioural changes in response to systemic
in!ammation, when measured in the same subject. “Immune
privilege as an intrinsic CNS property: astrocytes protect
the CNS against T-cell-mediated neuroin)ammation” by U.
Gimsa et al. is a review of the literature on neuroimmune
interactions between CNS astrocytes and peripheral T cells
that attempt to gain access into the CNS.)is review provides
evidence of these astrocyte-T cell interactions in both health
and disease. )e authors discuss mechanisms by which
astrocytes regulate T cells to help direct both pro- and
anti-in!ammatory responses. Overall, the authors review the
evidence that astrocytes regulate T cells at multiple check
points to help ensure neuroprotection andmaintenance of an
anti-in!ammatory environment within the CNS. “Activation
of protease-activated receptor 2-mediated signaling bymast cell
tryptase modulates cytokine production in primary cultured
astrocytes” byX. Zeng et al. is an original article that examined
the role of tryptase, which is a protease-activated receptor
(PAR)-2 agonist. Tryptase is produced by mast cells and
activates the PAR-2 receptor.)e authors show evidence that
tryptase increased IL-6 and TNF-a production by primary
astrocytes. Antagonism of PAR-2 prevented the induction
of these cytokines by primary astrocytes. Moreover, the
authors outlined two di,erent signaling pathways by which
tryptase promotes IL-6 (PI3-kinase dependent) and TNF in
astrocytes (P38/JNK-kinase dependent). Taken together this
data highlight a way in which peripheral immune cells (i.e.,
mast cells) can functionally communicate with astrocytes
and potentially in!uence in!ammatory responses within the
CNS. “ATP is required and advances cytokine-induced gap
junction formation in microglia in vitro” by P. J. Sa´ez et al.
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reports on the e,ects of ATP on microglial cells. In this
research article the authors use an in vitro approach to
study the function of microglial hemichannels and gap
junction channels, and their data support the idea that
extracellularATP a,ects the cellular communication between
microglia through autocrine and paracrine mechanisms.
“Possible involvement of TLRs and hemichannels in stress-
induced CNS dysfunction via mastocytes, and glia activation”
by A. Aguirre et al. reviews the involvement of a TLR-
mediated pathway to control neuroin!ammatory responses
within the CNS. )e authors suggest that mastocytes and
glial cells sense the in!ammatory tone, via TLR activation,
driving the release of in!ammatory mediators and further
ampli*cation of neural damage.
A signi*cant part of this special issue is devoted to the
study ofmultiple sclerosis, as a paradigmof immune-to-brain
communication. “Persistent in)ammation in the CNS during
chronic EAE despite local absence of IL-17 production” by S. F.
G. Zorzella-Pezavento et al. describes a study that investigates
the role of proin!ammatory cytokines in immune in*ltrates
during the acute and chronic diseases stages of experimental
allergic encephalitis (EAE). )e results show that the levels
of IFN-g are elevated in the periphery and CNS in both
the acute and chronic stages of disease. In contrast, IL-17
is only found in the CNS at the acute stages; the authors
suggest that this is due to a decline in Treg cells in the CNS
at the chronic phase. )e study did not investigate the role
of myeloid cells, which may be an alternative explanation
for persisting in*ltrates in the CNS, despite the lack of IL-17.
“Local overexpression of interleukin-11 in the central nervous
system limits demyelination and enhances remyelination” by
A. Maheshwari et al. provides evidence that IL-11 promotes
remyelination in the cuprizone model of demyelination
associated with reduced microglial activation. It remains to
know whether the e,ect of IL-11 on myelination is direct or
indirect via microglia/macrophages. “Growth arrest speci+c
gene 6 protein concentration in cerebrospinal )uid correlates
with relapse severity in multiple sclerosis” by P. P. Sainaghi et
al. reports a clinical study that shows a correlation of Gas-
6 in CSF with the severity of relapse in relapsing-remitting
multiple sclerosis patients. However, the Gas-6 levels in CSF
were not predictive for the long-term outcomes. “Regulation
of immune cell in+ltration into the CNS by regional neural
inputs explained by the gate theory” by Y. Arima et al. reviews
the modes of in*ltration of immune cells into the CNS
parenchyma. In particular, the authors propose the “gate
theory” as an alternative explanation for the control of cell
extravasation into the CNS in pathological conditions such
as multiple sclerosis.
Some articles focus on the study of the neuroimmune
component of neurodegenerative diseases such as Alzheim-
er’s or Parkinson’s, or other brain diseases. “Role of scavenger
receptors in glia-mediated neuroin)ammatory response as-
sociated with Alzheimer’s disease” by F. Cornejo and R.
von Bernhardi is a detailed review about the in!ammatory
mechanisms mediated by microglia and astroglia on the
pathological events in the Alzheimer’s disease, emphasizing
the relevance of A scavenger receptors for Ab clearance. “Role
of neuroin)ammation in adult neurogenesis and Alzheimer
disease: therapeutic approaches” by A. Fuster-Matanzo et al.
reviews the in!uence of the neuroin!ammatory component
of Alzheimer’s disease over the regulation of adult neu-
rogenesis, aiming at summarizing the reported e,ects of
several in!ammatory mediators and *nding new avenues
into potential therapeutic interventions. “Cellular and molec-
ular mediators of neuroin)ammation in the pathogenesis of
Parkinson’s disease” by S. V. More et al. reviews the current
evidence supporting a detrimental role of microglial cells
during the pathogenesis of Parkinson’s disease. Current evi-
dence from human studies highlights the neurotoxic activity
of diverse in!ammatory mediators or in*ltrated immune
cells in Parkinson’s disease, although further experimental
evidence is needed to fully understand the neuroin!am-
matory reaction in this pathology. “MMP-3 contributes to
nigrostriatal dopaminergic neuronal loss, BBB damage, and
neuroin)ammation in an MPTP mouse model of Parkinson’s
disease” byY. C. Chung et al. is an original research article that
examined the role of metalloproteases 3 (MMP3) in a mouse
model of Parkinson disease. )ese authors provide novel
evidence that matrix MMP3 plays a key role in increased
leukocyte in*ltration and dopaminergic cell loss a/er MPTP.
For instance, MMP3 knockout mice had attenuated damage
to the blood brain barrier (BBB), reduced in*ltration of ED-
1+ and CD3+ leukocytes, and reduced neuronal loss. More-
over, motor function was maintained in theMMP3 knockout
mice a/er MPTP injection compared to the wildtype MPTP-
injected mice.)us, MMP3-mediated breakdown of the BBB
and enhanced leukocyte in*ltration into the brain play a sig-
ni*cant role in nigrostriatal dopaminergic neuronal loss a/er
MPTP. “Are onconeural antibodies a clinical phenomenology
in paraneoplastic limbic encephalitis?” by H. Zhang et al. is a
detailed review about the role of brain-speci*c antibodies in
neurological diseases and in particular those associated with
peripheral malignancies. “,e causative pathogen determines
the in)ammatory pro+le in cerebrospinal )uid and outcome
in patients with bacterial meningitis” by D. Grandgirad et al.
is a clinical study that examined cerebrospinal !uid (CSF)
frompatients withmeningitis caused by one of three di,erent
pathogens (Streptococcus pneumonia, Neisseria mengitidis, or
Haemophilus in)uenza). )e authors’ *ndings indicate that
pneumococcal meningitis was associated with high levels of
in!ammatory mediators in the CSF including IFN-훾, MCP-1,
and MM9. Furthermore, the higher rates of fatal outcome in
patients with pneumococcal meningitis were associated with
correspondingly high levels of proin!ammatory cytokines in
the CSF including TNF-훼, IL-1훽, and IL-6. Overall, patients
with pneumococcal meningitis had an elevated CNS in!am-
matory response and higher mortality rate than patients
with either Neisseria mengitidis or Haemophilus in)uenza.
“Prognostic value of in)ammatorymediators in 1-year outcome
of acute ischemic stroke with middle cerebral artery stenosis”
by X. Gong et al. is a clinical study reporting the prognostic
value of diverse in!ammatory mediators in ischemic stroke.
Elevated hs-CRP was found to predict 1-year poor outcome
in acute stroke.)e combination of increased hs-CRP, WBC,
or HCY had a stronger predictive value in poor outcome than
individual elevated mediator.
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